Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A practical approach for evaluating population and individual bioequivalence.

A L Gould1

  • 1Merck Research Laboratories, West Point, PA, USA. goulda@merck.com

Statistics in Medicine
|October 18, 2000
PubMed
Summary

This study introduces a novel approach for assessing drug bioequivalence using standard 2x2 crossover designs. The method provides reliable evaluations of population and individual bioequivalence, offering an alternative to complex current proposals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strain-level diversity of symbiont communities between individuals and populations of a bioluminescent fish.

The ISME journal·2023
Same author

Chromosome-Level Genome Assembly of the Bioluminescent Cardinalfish Siphamia tubifer: An Emerging Model for Symbiosis Research.

Genome biology and evolution·2022
Same author

Life history of the symbiotically luminous cardinalfish Siphamia tubifer (Perciformes: Apogonidae).

Journal of fish biology·2016
Same author

Segregation effects on the properties of (AuAg)₁₄₇.

Physical chemistry chemical physics : PCCP·2014
Same author

Symbiosis initiation in the bacterially luminous sea urchin cardinalfish Siphamia versicolor.

Journal of fish biology·2012
Same author

Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone.

Diabetes, obesity & metabolism·2009

Area of Science:

  • Pharmacokinetics and Biopharmaceutics
  • Statistical Modeling in Drug Development

Background:

  • Drug formulation bioequivalence assessment is crucial for regulatory approval.
  • Current methods often rely on complex statistical models and designs, posing practical challenges.
  • Existing approaches may not fully capture the nuances of pharmacokinetic measurement distributions.

Purpose of the Study:

  • To present an alternative statistical approach for evaluating drug bioequivalence.
  • To enable assessment of population and individual bioequivalence using standard 2x2 crossover designs.
  • To offer a method that is statistically sound and practically applicable in clinical settings.

Main Methods:

  • Utilized pharmacokinetic measurements from two drug formulations.
  • Characterized the joint distribution of measurements using scale, correlation, and location parameters.

Related Experiment Videos

  • Employed correlation and regression coefficients for bioequivalence evaluation.
  • Applied the approach to standard 2x2 crossover designs.

    • Main Results:

    • The proposed approach provides evaluations for population and individual bioequivalence.
    • Results are consistent with current proposals when applied to FDA data.
    • In cases of discrepancy, the new approach demonstrated better data consistency.

    Conclusions:

    • The developed method offers a practical and statistically robust alternative for bioequivalence assessment.
    • It simplifies study designs compared to current complex proposals.
    • The approach is suitable for all practical clinical purposes and offers reliable bioequivalence conclusions.